4//SEC Filing
MAHON PAUL A 4
Accession 0001231589-25-000012
CIK 0001082554other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:32 PM ET
Size
19.0 KB
Accession
0001231589-25-000012
Insider Transaction Report
Form 4
MAHON PAUL A
EVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2025-12-11$146.03/sh+11,000$1,606,330→ 47,781 total - Sale
Common Stock
2025-12-11$482.22/sh−560$270,044→ 47,221 total - Sale
Common Stock
2025-12-11$483.25/sh−900$434,923→ 46,321 total - Sale
Common Stock
2025-12-11$484.31/sh−5,220$2,528,076→ 41,101 total - Sale
Common Stock
2025-12-11$485.22/sh−2,804$1,360,550→ 38,297 total - Sale
Common Stock
2025-12-11$486.36/sh−1,116$542,777→ 37,181 total - Sale
Common Stock
2025-12-11$487.37/sh−400$194,946→ 36,781 total - Exercise/Conversion
Stock Option
2025-12-11−11,000→ 20,250 totalExercise: $146.03From: 2020-03-15Exp: 2027-03-15→ Common Stock (11,000 underlying)
Footnotes (7)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $481.84 to $482.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $482.88 to $483.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $483.88 to $484.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $484.88 to $485.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $485.90 to $486.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $487.24 to $487.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001231589
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:32 PM ET
- Size
- 19.0 KB